LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL launched and commercial sales ongoing Funding commitments from U.S. Air Force Academy intended to advance ATI-1701 toward an IND...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, April 26, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI;...
Assets include the FDA-approved LIKMEZ™, the ATI-1701 tularemia vaccine defense program that has been awarded a USD $14 million non-dilutive award from the DoD, and the ATI-1801 topical...
Transaction consideration provides a significant premium to the Appili shareholders Combined enterprise expected to provide enhanced synergies and resources to advance key programs NOT FOR...
HALIFAX, Nova Scotia, March 12, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development...
FDA approved LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL Additional USAFA funding commitment from the U.S. Air Force Academy, intended to advance the ATI-1701 program toward an...
Patent coverage provides drug market exclusivity through at least 2039 Pre-IND meeting with the FDA granted to discuss ATI-1701’s regulatory, CMC, toxicology, and Phase 1 strategies Appili...
FDA approves ATI-1501 for Metronidazole Oral Suspension 500mg/5mL and its brand name LIKMEZ™ Appili received an additional funding commitment from the U.S. Air Force Academy for ATI-1701...
The morning opened up on a high note for this dually-listed company as it announced U.S. Food and Drug Administration (FDA) approval of its Metronidazole Oral Suspension 500mg/5mL ( ATI-1501 ) To...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.04 | 0.045 | 0.035 | 204955 | 0.04002927 | CS |
4 | 0.005 | 14.2857142857 | 0.035 | 0.05 | 0.035 | 133489 | 0.04116731 | CS |
12 | -0.0075 | -15.7894736842 | 0.0475 | 0.05 | 0.03 | 164851 | 0.03823627 | CS |
26 | 0 | 0 | 0.04 | 0.06 | 0.025 | 173284 | 0.03866617 | CS |
52 | 0.005 | 14.2857142857 | 0.035 | 0.08 | 0.025 | 209461 | 0.04675564 | CS |
156 | -0.73 | -94.8051948052 | 0.77 | 1.14 | 0.025 | 193170 | 0.12940135 | CS |
260 | -1.09 | -96.4601769912 | 1.13 | 1.6 | 0.025 | 179373 | 0.28803768 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.